Validity of composite end points in clinical trials

Victor M. Montori, Gaietà Permanyer-Miralda, Ignacio Ferreira-González, Jason W. Busse, Valeria Pacheco-Huergo, Dianne Bryant, Jordi Alonso, Elie A. Akl, Antònia Domingo-Salvany, Edward Mills, Ping Wu, Holger J. Schünemann, Roman Jaeschke, Gordon H. Guyatt

Research output: Contribution to journalReview articlepeer-review

275 Scopus citations

Abstract

Use of composite end points as the main outcome in randomised trials can hide wide differences in the individual measures. How should you apply the results to clinical practice?

Original languageEnglish (US)
Pages (from-to)594-596
Number of pages3
JournalBritish medical journal
Volume330
Issue number7491
DOIs
StatePublished - Mar 12 2005

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Validity of composite end points in clinical trials'. Together they form a unique fingerprint.

Cite this